Benign prostatic hyperplasia Diagnosis, Causes and Treatment Market by DelveInsight

September 22 11:14 2021
Benign prostatic hyperplasia Diagnosis, Causes and Treatment Market by DelveInsight

The Benign prostatic hyperplasia market report provides current treatment practices, emerging drugs, Benign prostatic hyperplasia (BPH) market share of the individual therapies, current and forecasted Benign prostatic hyperplasia (BPH) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current benign prostatic hyperplasia (BPH) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Benign prostatic hyperplasia Overview

Benign prostatic hyperplasia (BPH) is a noncancerous condition in men in which the prostate gland is enlarged. BPH is also called benign prostatic hypertrophy or benign prostatic obstruction. The prostate goes through two main growth periods as a man ages. The first occurs early in puberty when the prostate doubles in size. The second phase of growth begins around age 25 and continues during most of a man’s life. BPH often occurs with the second growth phase. 

 

Download free sample copy- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-market

 

List of regions covered in the report

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

 

List of Benign Prostatic Hyperplasia companies involved in the report

  • Abbott Laboratories
  • Pfizer
  • And many others

 

Benign prostatic hyperplasia Cause

The cause of BPH is not well understood; however, it is most common in old men. As BPH does not develop in men whose testicles were removed before puberty, some researchers believe factors related to aging and the testicles are the underlying causes.

 

Benign prostatic hyperplasia Diagnosis

The diagnosis of BPH can be made by examining personal or family history, physical examination and medical tests. The American Urological Association (AUA) has built a BPH Symptom Score Index. It’s a series of questions about how often urinary symptoms happen. The score rates BPH from mild to severe.

 

Benign prostatic hyperplasia Treatment Market

The treatment of BPH includes lifestyle changes, medications, minimally invasive procedures, and surgery. It covers the details of conventional and current medical therapies available in the benign prostatic hyperplasia (BPH) market for the treatment of the condition. It also provides benign prostatic hyperplasia (BPH) treatment algorithms and guidelines in the United States, Europe, and Japan.

 

Benign prostatic hyperplasia Market Insight

The treatment of BPH includes watchful waiting, medical therapies, minimally invasive surgery, and surgery. Watchful waiting is the recommended strategy for patients with BPH who have mild symptoms and for those with moderate-to-severe symptoms who are not bothered by their symptoms and are not experiencing complications of BPH.

 

Benign prostatic hyperplasia Market Forecast

The smooth muscle tension is mediated by alpha-1-adrenergic receptors; hence, alpha-adrenergic receptor–blocking agents relax the smooth muscle, thus allowing easier passage of urine. Based on the receptor subtype selectivity and the duration of serum elimination half-lives, they are categorized into nonselective alpha-blockers (phenoxybenzamine), selective short-acting alpha-1 blockers (prazosin, alfuzosin, indoramin), selective long-acting alpha-1 blockers (terazosin, doxazosin, slow-release alfuzosin), and partially subtype (alpha-1a)–selective agents (tamsulosin (Flomax), silodosin (Rapaflo)).

 

Download free sample copy- https://www.delveinsight.com/sample-request/benign-prostatic-hyperplasia-bph-market

 

Table of content

1. Key Insights

2. Executive Summary of Benign prostatic hyperplasia (BPH)

3. Competitive Intelligence Analysis for Benign prostatic hyperplasia (BPH)

4. Benign prostatic hyperplasia (BPH): Market Overview at a Glance

5. Benign prostatic hyperplasia (BPH): Disease Background and Overview

6. Patient Journey

7. Benign prostatic hyperplasia (BPH) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Benign prostatic hyperplasia (BPH) Treatment

11. Marketed Products

12. Emerging Therapies

13. Benign prostatic hyperplasia (BPH): Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Benign prostatic hyperplasia (BPH)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Benign prostatic hyperplasia Market Report Highlights

  • In the coming years, Benign prostatic hyperplasia (BPH) market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
  • The companies and academics are working to assess challenges and seek opportunities that could influence Benign prostatic hyperplasia (BPH) R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition      
  • Major players are involved in developing therapies for Benign prostatic hyperplasia (BPH). Launch of emerging therapies will significantly impact the Benign prostatic hyperplasia (BPH) market
  • A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Benign prostatic hyperplasia (BPH)
  • Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

view more articles

About Article Author